Camden National Bank’s Hologic HOLX Stock Holding History

Camden National Bank’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,340	Closed	-$241K	–	167
2024 Q4	$241K	Buy	+3,340	New	+$261K	0.04%	146

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Camden National Bank's HOLX Position: Q1 2025 in Review

Camden National Bank sold out of Hologic (HOLX) in Q1 2025, closing a stake of 3,340 shares — an estimated $241K sold.

Camden National Bank first reported a position in HOLX in Q4 2024 and held it in 1 quarter. The position peaked at $241K in Q4 2024. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

Camden National Bank reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
Camden National Bank sold 3,340 Hologic shares in Q1 2025, an estimated $241K.
Camden National Bank first reported a position in Hologic in Q4 2024 and held it in 1 quarter.
Camden National Bank's Hologic position peaked at $241K in Q4 2024.
706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Camden National Bank's 13F filing for Q1 2025, filed 13 May 2025.